Electra Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Electra Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ETRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002088082
Board of directors
- Since 2026
-
Matthew K. Fust · DirectorSince 2026
-
Nancy Stagliano · DirectorSince 2026
-
Quehuong (Kathy) Dong · Director · President & CEOSince 2026
Chief executives
Quehuong (Kathy) Dong
· President & CEO
Since September 2026
Board connections
2 of this board's directors also sit on 10 other boards.
- via Carl L. Gordon
- via Carl L. Gordon
- via Matthew K. Fust
- via Carl L. Gordon
- via Carl L. Gordon
- via Carl L. Gordon
- via Carl L. Gordon
- via Matthew K. Fust
- via Carl L. Gordon
- via Matthew K. Fust
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $39,999,990
- 4 purchases by 2 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 21, 2026 | Quehuong (Kathy) Dong Director, Officer (President & CEO) | Derivative conversion | +455,484 | — | — |
| Sep 21, 2026 | Nancy Stagliano Director | Derivative conversion | +255,635 | — | — |
| Sep 21, 2026 | Koe Gary S. Officer (Chief Technical Officer) | Derivative conversion | +63,656 | — | — |
| Sep 21, 2026 | Parry Graham Officer (Chief Scientific Officer) | Derivative conversion | +85,504 | — | — |
| Sep 21, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Derivative conversion | +2,002,310 | — | — |
| Sep 21, 2026 | Carl L. Gordon Director, 10% owner | Derivative conversion | +2,002,310 | — | — |
| Sep 21, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Derivative conversion | +1,087,934 | — | — |
| Sep 21, 2026 | Carl L. Gordon Director, 10% owner | Derivative conversion | +1,087,934 | — | — |
| Sep 21, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Derivative conversion | +1,703,314 | — | — |
| Sep 21, 2026 | Carl L. Gordon Director, 10% owner | Derivative conversion | +1,703,314 | — | — |
| Sep 21, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +333,333 | $15.00 | $4,999,995 |
| Sep 21, 2026 | Carl L. Gordon Director, 10% owner | Open-market purchase | +333,333 | $15.00 | $4,999,995 |
| Sep 21, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Derivative conversion | +758,279 | — | — |
| Sep 21, 2026 | Carl L. Gordon Director, 10% owner | Derivative conversion | +758,279 | — | — |
| Sep 21, 2026 | ORBIMED ADVISORS LLC Director, 10% owner | Open-market purchase | +1,000,000 | $15.00 | $15,000,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.